The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapyTsutomu Iwata, Midori Shimada, K. Koyama et al.|PLoS ONE|2017Cited by 13
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutationsEiji Iwama, Isamu Okamoto, Kazuko Sakai et al.|Lung Cancer|2025Cited by 3